|
| CasyDrogueIn terms of Regulation 24 A of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements Regulations, 2015, we enclose Secretarial Compliance Report duly issued by N. http://ycs.instructure.com/eportfolios/3498/Anavario_10_Mg_Kratom http://apple-sandbox.instructure.com/eportfolios/516/Beclate_Inhaler_200_Mcg_Overdose http://esc7.instructure.com/eportfolios/319/Roaccutane_Capsule_10_Mg 縺ゅ縺 メッセージ |
|